Literature DB >> 25286946

Crystallization and preliminary X-ray diffraction analysis of the BRPF1 bromodomain in complex with its H2AK5ac and H4K12ac histone-peptide ligands.

Mulu Y Lubula1, Amanda Poplawaski1, Karen C Glass1.   

Abstract

The bromodomain-PHD finger protein 1 (BRPF1) is an essential subunit of the monocytic leukemia zinc (MOZ) histone acetyltransferase (HAT) complex and is required for complex formation and enzymatic activation. BRPF1 contains a structurally conserved bromodomain, which recognizes specific acetyllysine residues on histone proteins. The MOZ HAT plays a direct role in hematopoiesis, and deregulation of its activity is linked to the development of acute myeloid leukemia. However, the molecular mechanism of histone-ligand recognition by the BRPF1 bromodomain is currently unknown. The 117-amino-acid BRPF1 bromodomain was overexpressed in Escherichia coli and purified to homogeneity. Crystallization experiments of the BRPF1 bromodomain in complex with its H4K12ac and H2AK5ac histone ligands yielded crystals that were suitable for high-resolution X-ray diffraction analysis. The BRPF1 bromodomain-H4K12ac crystals belonged to the tetragonal space group P43212, with unit-cell parameters a = 75.1, b = 75.1, c = 86.3 Å, and diffracted to a resolution of 1.94 Å. The BRPF1 bromodomain-H2AK5ac crystals grew in the monoclinic space group P21, with unit-cell parameters a = 60.9, b = 55.6, c = 82.1 Å, β = 93.6°, and diffracted to a resolution of 1.80 Å. Complete data sets were collected from both crystal forms using synchrotron radiation on beamline X29 at Brookhaven National Laboratory (BNL).

Entities:  

Keywords:  BRPF1 bromodomain; H2AK5ac; H4K12ac

Mesh:

Substances:

Year:  2014        PMID: 25286946      PMCID: PMC4188086          DOI: 10.1107/S2053230X14018433

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  29 in total

Review 1.  Structure and acetyl-lysine recognition of the bromodomain.

Authors:  S Mujtaba; L Zeng; M-M Zhou
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

2.  BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Authors:  Jake E Delmore; Ghayas C Issa; Madeleine E Lemieux; Peter B Rahl; Junwei Shi; Hannah M Jacobs; Efstathios Kastritis; Timothy Gilpatrick; Ronald M Paranal; Jun Qi; Marta Chesi; Anna C Schinzel; Michael R McKeown; Timothy P Heffernan; Christopher R Vakoc; P Leif Bergsagel; Irene M Ghobrial; Paul G Richardson; Richard A Young; William C Hahn; Kenneth C Anderson; Andrew L Kung; James E Bradner; Constantine S Mitsiades
Journal:  Cell       Date:  2011-09-01       Impact factor: 41.582

3.  Prognosis of patients with t(8;16)(p11;p13) acute myeloid leukemia.

Authors:  Tanya Brown; John Swansbury; Mary M Taj
Journal:  Leuk Lymphoma       Date:  2011-09-23

4.  Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).

Authors:  Su Qin; Lei Jin; Jiahai Zhang; Lei Liu; Peng Ji; Mian Wu; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

5.  Combinatorial readout of unmodified H3R2 and acetylated H3K14 by the tandem PHD finger of MOZ reveals a regulatory mechanism for HOXA9 transcription.

Authors:  Yu Qiu; Lei Liu; Chen Zhao; Chuanchun Han; Fudong Li; Jiahai Zhang; Yan Wang; Guohong Li; Yide Mei; Mian Wu; Jihui Wu; Yunyu Shi
Journal:  Genes Dev       Date:  2012-06-15       Impact factor: 11.361

6.  Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1.

Authors:  Alessandro Vezzoli; Nicolas Bonadies; Mark D Allen; Stefan M V Freund; Clara M Santiveri; Brynn T Kvinlaug; Brian J P Huntly; Berthold Göttgens; Mark Bycroft
Journal:  Nat Struct Mol Biol       Date:  2010-04-18       Impact factor: 15.369

7.  MOZ is essential for maintenance of hematopoietic stem cells.

Authors:  Takuo Katsumoto; Yukiko Aikawa; Atsushi Iwama; Shinobu Ueda; Hitoshi Ichikawa; Takahiro Ochiya; Issay Kitabayashi
Journal:  Genes Dev       Date:  2006-05-15       Impact factor: 11.361

8.  Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.

Authors:  Mireia Camós; Jordi Esteve; Pedro Jares; Dolors Colomer; María Rozman; Neus Villamor; Dolors Costa; Ana Carrió; Josep Nomdedéu; Emili Montserrat; Elías Campo
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

9.  The NoRC complex mediates the heterochromatin formation and stability of silent rRNA genes and centromeric repeats.

Authors:  Claudio Guetg; Philipp Lienemann; Valentina Sirri; Ingrid Grummt; Danièle Hernandez-Verdun; Michael O Hottiger; Martin Fussenegger; Raffaella Santoro
Journal:  EMBO J       Date:  2010-02-18       Impact factor: 11.598

10.  RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination.

Authors:  Adam G W Matthews; Alex J Kuo; Santiago Ramón-Maiques; Sunmi Han; Karen S Champagne; Dmitri Ivanov; Mercedes Gallardo; Dylan Carney; Peggie Cheung; David N Ciccone; Kay L Walter; Paul J Utz; Yang Shi; Tatiana G Kutateladze; Wei Yang; Or Gozani; Marjorie A Oettinger
Journal:  Nature       Date:  2007-11-21       Impact factor: 49.962

View more
  2 in total

Review 1.  Biological function and histone recognition of family IV bromodomain-containing proteins.

Authors:  Jonathan T Lloyd; Karen C Glass
Journal:  J Cell Physiol       Date:  2017-06-13       Impact factor: 6.384

2.  Structural insights into recognition of acetylated histone ligands by the BRPF1 bromodomain.

Authors:  Mulu Y Lubula; Brian E Eckenroth; Samuel Carlson; Amanda Poplawski; Maksymilian Chruszcz; Karen C Glass
Journal:  FEBS Lett       Date:  2014-09-30       Impact factor: 4.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.